Back
Harmony Biosciences Holdings, Inc. 10K Form
Buy
73
HRMY
Harmony Biosciences Holdings, Inc.
Last Price:
$38.92
Seasonality Move:
-9.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HRMY News And Ratings
See the #1 stock for the next 7 days that we like better than HRMY
HRMY Financial Statistics
Sales & Book Value
| Annual Sales: | $714.7M |
|---|---|
| Cash Flow: | $108.7M |
| Price / Cash Flow: | 7.65 |
| Annual Sales: | $14.50 |
| Price / Book: | 2.68 |
Profitability
| EPS (TTM): | 3.17540 |
|---|---|
| Net Income (TTM): | $185.7M |
| Gross Margin: | $534.1M |
| Return on Equity: | 25.9% |
| Return on Assets: | 17.52% |
Harmony Biosciences Holdings, Inc. Earnings Forecast
Key Harmony Biosciences Holdings, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for HRMY is 74.72%.
-
The Selling, General & Administrative Expenses for HRMY have been equal to 30.96% of Gross Profit Margin.
-
The Research & Development expenses have been 20.40% of Revenue.
-
The Interest Expense is 12.03% of Operating Income.
-
The Net Earning history of HRMY is 20.36% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 4 years.
Harmony Biosciences Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | HRMY |
| Website: | harmonybiosciences.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 3.75 |
| Quick Ratio: | 3.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 15.44 |
|---|---|
| Forward P/E Ratio: | 6.91 |
HRMY Technical Analysis vs Fundamental Analysis
Buy
73
Harmony Biosciences Holdings, Inc. (HRMY)
is a Buy
Is Harmony Biosciences Holdings, Inc. a Buy or a Sell?
-
Harmony Biosciences Holdings, Inc. stock is rated a BuyThe current Harmony Biosciences Holdings, Inc. [HRMY] share price is $38.83. The Score for HRMY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.